<DOC>
	<DOCNO>NCT00535197</DOCNO>
	<brief_summary>The aim study determine safety tolerability autologous CD34+ subset bone marrow stem cell infusion middle cerebral artery patient suffer acute total partial anterior circulation syndrome ( TACS/PACS ) .</brief_summary>
	<brief_title>Autologous Bone Marrow Stem Cells Ischemic Stroke .</brief_title>
	<detailed_description>The propose trial involve recruitment total 10 patient . The cell collect subject recruit , via bone marrow sample . CD34+ stem cell isolate harvested process immuno-selection accordance principle Good Manufacturing Practice . The CD34+ cell directly infuse area stroke intra-arterially use middle cerebral artery . Initially , investigator monitor patient period 6 month post-stem cell infusion . Thereafter , revert previous treatment regime clinic . Assessment adverse event physical examination measurement laboratory parameter . Assessment efficacy physical examination measurement laboratory , CT MRI parameter .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<criteria>Symptoms sign clinically definite acute stroke Time stroke onset know treatment start within 7 day onset CT MRI brain scanning reliably exclude intracranial haemorrhage structural brain lesion mimic stroke ( e.g . cerebral tumour ) The stroke severe conform TACS phenotype ( weakness , homonymous hemianopia focal cognitive deficit ( e.g . aphasia ) reduction consciousness ) PACS phenotype ( two three TACS criterion ) An age range 3080 year old Stroke confine MCA territory CT MRI brain image NIHSS score &gt; /= 8 Known defect clot platelet function ( patient antiplatelet agent enrol ) Haematological cause stroke Severe comorbidity Hepatic renal dysfunction The patient female childbearing potential ( unless certain pregnancy possible ) breast feed Hypo hyperglycaemia sufficient account neurological symptom ; patient exclude blood glucose &lt; 3.0 &gt; 20.0mmol/L Patient likely unavailable followup e.g . fix home address Patients evidence life threaten infection ( e.g . HIV ) life threaten illness ( e.g . advanced cancer ) Patient already dependent activity daily live present acute stroke Patients include clinical trial within previous month</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>